Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziv Oren

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Viruses|April 23, 2022
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic PlagueYaron Vagima, David Gur, Moshe Aftalion, et al.
Biotech (Basel (Switzerland))|July 13, 2022
Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through ChromatographyElad Lerer, Ziv Oren, Yaron Kafri, et al.
Vaccine|November 10, 2021
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidateArik Makovitzki, Elad Lerer, Yaron Kafri, et al.
Frontiers in Bioengineering and Biotechnology|March 7, 2024
Enhanced production yields of rVSV-SARS-CoV-2 vaccine using Fibra-Cel<sup>®</sup> macrocarriersNoam Cohen, Irit Simon, Ophir Hazan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Viruses|April 23, 2022
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic PlagueYaron Vagima, David Gur, Moshe Aftalion, et al.
Biotech (Basel (Switzerland))|July 13, 2022
Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through ChromatographyElad Lerer, Ziv Oren, Yaron Kafri, et al.
Vaccine|November 10, 2021
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidateArik Makovitzki, Elad Lerer, Yaron Kafri, et al.
Frontiers in Bioengineering and Biotechnology|March 7, 2024
Enhanced production yields of rVSV-SARS-CoV-2 vaccine using Fibra-Cel<sup>®</sup> macrocarriersNoam Cohen, Irit Simon, Ophir Hazan, et al.
Pageof 2